BIOA bioagelabs.com Net earnings per share for the last 12 months

Public company logo of BioAge Labs, Inc. (BIOA)

The 12-month EPS trend for BioAge Labs, Inc. (BIOA) demonstrates the impact of geopolitical barriers and sanctions on supply chains, where the value -2.56 represents the current metric. While the company's success relies on high-tech bio-logistics for sample transportation, a critical dependence on external capital and the risks of clinical trial failures pose serious threats in its competition against pharma behemoths.

BIOA (BioAge Labs, Inc) Net earnings per share (EPS TTM) history from 09/27/2024 to 11/15/2026

Analytical breakdowns and data insights for company BioAge Labs, Inc (BIOA)

- stock price and consensus target price:
Stock Price BioAge Labs, Inc|BIOA - Average Forecast Price
- market capitalization data:
Market Valuation BioAge|BIOA - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share BioAge Labs, Inc.|BIOA - Book Capitalization|Market Capitalization to Book Value Ratio bioagelabs.com|BIOA - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity BioAge Labs, Inc.|BIOA - Long-Term Liabilities to Capital|Short-Term Debt to Equity BioAge Labs, Inc.|BIOA - Company Debts|Debts to Book Capitalization BioAge Labs, Inc.|BIOA - Long-Term Debt Volume|Company Short-Term Debt BioAge Labs, Inc.|Quick Liquidity bioagelabs.com
- net income and valuation multiples indicators:
BIOA - Net Income|Projected Future Earnings BioAge Labs, Inc.|BIOA - Price to Earnings Ratio|Forward P/E Multiple BioAge Labs, Inc|BIOA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioAge|BIOA - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) BioAge Labs, Inc.|BIOA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bioagelabs.com|BIOA - Net earnings per share change in current year|Earnings growth forecast for next year BioAge Labs, Inc.
- sales and revenue data:
BIOA - Company Total Revenue|Company Future Sales Volume BioAge|BIOA - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio BioAge Labs Inc.
Fundamental company valuation:BioAge Labs (BIOA)
Mass-produced product of BioAge Labs Inc.

BioAge Labs, Inc. (BIOA) aims for dominance in the obesity and aging segments by integrating AI analytics into clinical development. An analysis of the company's annual net profit per unit allows for an assessment of the real earnings per share over 12 months, separating fundamental results from market noise, which helps investors distinguish a true trend reversal from a temporary bounce within a venture strategy.

Competitors of BioAge Labs, Inc.

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biomea Fusion Corp BMEA|QNCX: Net earnings per share (EPS TTM)|Fractyl Health, Inc. (GUTS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months VTVT|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS